SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,503.87 -105.21
(-0.99%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

24.91

29563.89

EPS(TTM)

Face Value()

Div & Yield %

72.04

Back

golden universal limited

Capital India Finance consolidated net profit rises 1364.71% in the September 2025 quarter

Nov 15,2025

Net profit of Capital India Finance rose 1364.71% to Rs 44.82 crore in the quarter ended September 2025 as against Rs 3.06 crore during the previous quarter ended September 2024. Sales declined 8.71% to Rs 129.59 crore in the quarter ended September 2025 as against Rs 141.95 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	129.59	141.95	-9
OPM %	-20.83	15.40	-
PBDT	-46.00	6.96	PL
PBT	-54.11	-0.81	-6580
NP	44.82	3.06	1365

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,503.87 -105.21 (-0.99%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)